Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125083782 | 12508378 | 2 | F | 201602 | 20160707 | 20160629 | 20160719 | EXP | US-ACORDA-ACO_125355_2016 | ACORDA | 58.07 | YR | M | Y | 0.00000 | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125083782 | 12508378 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | 10 MG, UNK | 22250 | 10 | MG | TABLET | ||||||||
| 125083782 | 12508378 | 2 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | Unknown | 3 ML, TID | U | 0 | 3 | ML | TID | ||||||
| 125083782 | 12508378 | 3 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Oral | 2 PUFFS, Q 6 HRS | U | 0 | Q6H | ||||||||
| 125083782 | 12508378 | 4 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
| 125083782 | 12508378 | 5 | C | ENALAPRIL MALEATE. | ENALAPRIL MALEATE | 1 | Unknown | 5 MG, BID | U | 0 | 5 | MG | TABLET | BID | |||||
| 125083782 | 12508378 | 6 | C | AVONEX | INTERFERON BETA-1A | 1 | Unknown | 30 ?G, WEEKLY | U | 0 | 30 | UG | /wk | ||||||
| 125083782 | 12508378 | 7 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 10 MG, QID | U | 0 | 10 | MG | TABLET | QID | |||||
| 125083782 | 12508378 | 8 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, QD | U | 0 | 81 | MG | TABLET | QD | |||||
| 125083782 | 12508378 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 1000 IU, QD | U | 0 | 1000 | IU | TABLET | QD | |||||
| 125083782 | 12508378 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 125083782 | 12508378 | 11 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | 800 MG, TID | U | 0 | 800 | MG | TID | ||||||
| 125083782 | 12508378 | 12 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Unknown | 25 ?G, QD | U | 0 | 25 | UG | QD | ||||||
| 125083782 | 12508378 | 13 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 750 MG, BID | U | 0 | 750 | MG | BID | |||||||
| 125083782 | 12508378 | 14 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | 100 MG, QD | U | 0 | 100 | MG | QD | ||||||
| 125083782 | 12508378 | 15 | C | Atorvastatin | ATORVASTATIN | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 125083782 | 12508378 | 16 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Oral | 50 ?G, BID | U | 0 | 50 | UG | INHALER | BID | |||||
| 125083782 | 12508378 | 17 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | Unknown | 1 %, BID | U | 0 | 1 | PCT | CREAM | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125083782 | 12508378 | 1 | Multiple sclerosis |
| 125083782 | 12508378 | 2 | Wheezing |
| 125083782 | 12508378 | 3 | Wheezing |
| 125083782 | 12508378 | 4 | Dyspnoea |
| 125083782 | 12508378 | 5 | Product used for unknown indication |
| 125083782 | 12508378 | 6 | Product used for unknown indication |
| 125083782 | 12508378 | 7 | Product used for unknown indication |
| 125083782 | 12508378 | 8 | Product used for unknown indication |
| 125083782 | 12508378 | 9 | Product used for unknown indication |
| 125083782 | 12508378 | 10 | Gastrooesophageal reflux disease |
| 125083782 | 12508378 | 11 | Product used for unknown indication |
| 125083782 | 12508378 | 12 | Product used for unknown indication |
| 125083782 | 12508378 | 13 | Diabetes mellitus |
| 125083782 | 12508378 | 14 | Product used for unknown indication |
| 125083782 | 12508378 | 15 | Blood cholesterol |
| 125083782 | 12508378 | 16 | Dyspnoea |
| 125083782 | 12508378 | 17 | Rash |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125083782 | 12508378 | OT |
| 125083782 | 12508378 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125083782 | 12508378 | Cerebrovascular accident | |
| 125083782 | 12508378 | Dysarthria | |
| 125083782 | 12508378 | Facial paralysis | |
| 125083782 | 12508378 | Injection site erythema | |
| 125083782 | 12508378 | Multiple sclerosis relapse | |
| 125083782 | 12508378 | Seizure like phenomena | |
| 125083782 | 12508378 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125083782 | 12508378 | 2 | 20120405 | 0 | ||
| 125083782 | 12508378 | 3 | 20130528 | 0 | ||
| 125083782 | 12508378 | 5 | 20120328 | 0 | ||
| 125083782 | 12508378 | 6 | 20100616 | 0 | ||
| 125083782 | 12508378 | 7 | 20141117 | 0 | ||
| 125083782 | 12508378 | 8 | 20110414 | 0 | ||
| 125083782 | 12508378 | 9 | 20110414 | 0 | ||
| 125083782 | 12508378 | 10 | 20110713 | 0 | ||
| 125083782 | 12508378 | 11 | 20121129 | 0 | ||
| 125083782 | 12508378 | 12 | 20121214 | 0 | ||
| 125083782 | 12508378 | 13 | 20131021 | 0 | ||
| 125083782 | 12508378 | 14 | 20150522 | 0 | ||
| 125083782 | 12508378 | 15 | 20150226 | 0 | ||
| 125083782 | 12508378 | 16 | 20151110 | 0 | ||
| 125083782 | 12508378 | 17 | 20160627 | 0 |